Business Context and Reporting Period
This Form 8-K is a current report filed by BioSig Technologies, Inc. (not Streamex Corp.) on October 6, 2022, covering the event date of September 30, 2022. The company is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a specific corporate event rather than periodic financial performance.
Material Changes
On September 30, 2022, the Company executed a purchase agreement with San Antonio Methodist Hospital. This agreement provides for the acquisition of the Company's PURE EP® System by the hospital.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors beyond the disclosure of the new sales agreement. No unusual items or contingencies were disclosed in this text.
Investor Verification Checklist
- Verify the total contract value and payment terms of the PURE EP® System agreement with San Antonio Methodist Hospital.
- Confirm the expected delivery timeline and revenue recognition schedule for this transaction.
- Review recent 10-Q or 10-K filings for the company's overall financial health, as this 8-K contains no financial statements.